Jeffrey Robinson - Wuhan General Chairman Founder

WUHNDelisted Stock  USD 0.0004  0.00  0.00%   

Insider

Jeffrey Robinson is Chairman Founder of Wuhan General Gr
Phone514-928-7368
Webhttps://wuhn.org

Jeffrey Robinson Latest Insider Activity

Tracking and analyzing the buying and selling activities of Jeffrey Robinson against Wuhan General pink sheet is an integral part of due diligence when investing in Wuhan General. Jeffrey Robinson insider activity provides valuable insight into whether Wuhan General is net buyers or sellers over its current business cycle. Note, Wuhan General insiders must abide by specific rules, including filing SEC forms every time they buy or sell Wuhan General'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Wuhan General Management Efficiency

Wuhan General's management efficiency ratios could be used to measure how well Wuhan General manages its routine affairs as well as how well it operates its assets and liabilities.
Wuhan General Gr currently holds 118.8 M in liabilities with Debt to Equity (D/E) ratio of 1.11, which is about average as compared to similar companies. Wuhan General Gr has a current ratio of 1.08, suggesting that it may not have the ability to pay its financial obligations when due. Debt can assist Wuhan General until it has trouble settling it off, either with new capital or with free cash flow. So, Wuhan General's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Wuhan General Gr sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Wuhan to invest in growth at high rates of return. When we think about Wuhan General's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Bryan MurrayAcreage Holdings
N/A
Steven GoertzAcreage Holdings
52
France LandryCannara Biotech
N/A
Mba BEconAvicanna
N/A
John BarnetAurora Cannabis
N/A
James SabiaCanopy Growth Corp
59
Robbie MadanSNDL Inc
45
Steve WestAcreage Holdings
N/A
Corey BurchmanAcreage Holdings
N/A
James HolmCronos Group
41
Ryan HellardSNDL Inc
35
David AbitbolCannara Biotech
N/A
Ivana MaricAvicanna
N/A
Thomas LarssenAurora Cannabis
N/A
Edward KremerCuraleaf Holdings
51
Jimes SabiaCanopy Growth Corp
58
Robert HansonCanopy Growth Corp
57
Joseph BayernCuraleaf Holdings
60
Lance FriedmannAurora Cannabis
65
Alexander WolfeCannara Biotech
N/A
Roland AlvarezAvicanna
N/A
Wuhan General Group , Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol -based products under the Dr. Wuhan General Group , Inc. is headquartered in Pointe-Claire, Canada. Wuhan General operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 700 people. Wuhan General Gr [WUHN] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. Wuhan General is listed under Machinery category by Fama And French industry classification.

Management Performance

Wuhan General Gr Leadership Team

Elected by the shareholders, the Wuhan General's board of directors comprises two types of representatives: Wuhan General inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Wuhan. The board's role is to monitor Wuhan General's management team and ensure that shareholders' interests are well served. Wuhan General's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Wuhan General's outside directors are responsible for providing unbiased perspectives on the board's policies.
Anna Morera, Chief Medical Officer
Carol Pan, Principal Officer
Luka MSc, Director Communication
Huang Zhaoqi, Vice Director
Johann Mcloughlin, Head Design
Shivani Subudhi, Head Marketing
Willem Jonker, Chief Officer
Samuel Williams, Head Foods
Jeffrey Robinson, Chairman Founder
AAg MSc, Chief Officer

Wuhan Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Wuhan General a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Wuhan General

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Wuhan General position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan General will appreciate offsetting losses from the drop in the long position's value.

Moving together with Wuhan Pink Sheet

  0.67EGRX Eagle PharmaceuticalsPairCorr

Moving against Wuhan Pink Sheet

  0.73YCBD-PA cbdMD IncPairCorr
  0.72INIS International IsotopesPairCorr
  0.69HROWM Harrow Health, 11875PairCorr
  0.58PETQ PetIQ IncPairCorr
  0.54ELTP Elite PharmaPairCorr
The ability to find closely correlated positions to Wuhan General could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wuhan General when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wuhan General - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wuhan General Gr to buy it.
The correlation of Wuhan General is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wuhan General moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wuhan General Gr moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Wuhan General can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Wuhan Pink Sheet

If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Transaction History
View history of all your transactions and understand their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio